Modern Vision Centers Highlights EVO ICL as a Lens-Based Alternative to LASIK for Patients in West Des Moines and Beyond

West Des Moines, Iowa - February 25, 2026 - PRESSADVANTAGE - Modern Vision Centers is drawing national attention to the ...

STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses ...
Business Wire

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...

STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years

STAAR Surgical jumps 8% after the FDA expands the EVO ICL age range to 21-60, backed by strong safety data and rising demand ...
Seeking Alpha

Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL

Oct. 10, 2023 10:51 AM ETSTAAR Surgical Company (STAA) STAAR Surgical is equally enthusiastic about this collaboration. Tom Frinzi, CEO of STAAR Surgical, states, "We are happy to have Jimmy O. Yang ...
Business Wire

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction

In parallel with these market trends, long-term clinical evidence for EVO ICL continues to strengthen. In the FDA clinical trial, 629 eyes were followed for three years, demonstrating a strong safety ...
Nasdaq

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch – achieving market leadership ...
KELOLAND News

Vance Thompson Vision explains Implantable Collamer Lenses

Clear, sharp vision is a game-changer, and for those seeking an alternative to LASIK, Implantable Collamer Lens or ICL surgery offers an innovative solution. Unlike laser-based procedures, ICL ...
USA Today

Dr. Jason Brinton Selected as Principal Investigator for Landmark FDA Study Demonstrating Superior Safety and Efficacy of EVO ICL Technology

Prestigious three-year multicenter clinical trial confirms revolutionary implantable lens technology achieves exceptional visual outcomes with minimal complications Dr. Jason P. Brinton of Brinton ...